Skip to content

Observation of curative effect of Subacute thyroiditis treated by Subparty A (excessive heat and toxin accumulation, blood heat and blood stasis)

Observation of curative effect of Subacute thyroiditis treated by Subparty A (excessive heat and toxin accumulation, blood heat and blood stasis)

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037332
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subacute granulomatous thyroiditis, SAT

Interventions

Sponsors

Shanghai Sixth People's Hospital East Campus
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years; 2. Meet the diagnostic criteria of western medicine for subacute thyroiditis; 3. Meet the diagnostic criteria of traditional Chinese medicine heat toxin Yongsheng and blood heat mixed blood stasis; 4. No long-term chronic diseases such as diabetes, hypertension and kidney disease, and no long-term medication for lowering blood glucose, lipid and blood pressure; 5. Those who voluntarily cooperate with the clinical trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Complicated with cardiovascular and cerebrovascular, liver, hematopoietic system and other serious diseases, with glucocorticoid contraindication; 2. Allergic constitution, or pregnant or lactating women; 3. Patients who have participated in other clinical trials in recent 3 months; 4. Patients with mental illness, infection, tumor, osteoporosis, acute suppurative thyroiditis, thyroid hemorrhage; 5. Abnormal safety indicators such as liver function, kidney function, electrocardiogram and urine routine before taking medicine; 6. Clinical judgment of critical condition requiring hospitalization; 7. Comprehensive judgment of various factors and follow-up of difficult patients in later stage.

Design outcomes

Primary

MeasureTime frame
FT3;FT4;TSH;TG;TGAb;TPOAb;CRP;Ultrasound examination of thyroid type B;

Countries

China

Contacts

Public ContactWangfeng

Shanghai Sixth People's Hospital East Campus

phenix_wang@126.com+86 13262982817

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026